Insider Trade: John Cahill Unloaded 7,000 Shares of Colgate-Palmolive Company (CL); AMATA CORPORATION PUBLIC COMPANY LTD FOR (AMCZF) Shorts Up By 97.13%

director, John Cahill is the Colgate Palmolive Co’s insider who sold shares of Colgate Palmolive Co, 7,000 to be exact. The mentioned shares were based on a market price per share of $70.0, with John Cahill’s sale valued at near $489,696 U.S. Dollars. Presently, John Cahill possess a total of 39,237 shares or 0.00% of the company’s market capitalization (total value of the shares outstanding). John completed this trade on 15/02/2018. The report is on hand here at the SEC website.

AMATA CORPORATION PUBLIC COMPANY LTD FOR (OTCMKTS:AMCZF) had an increase of 97.13% in short interest. AMCZF’s SI was 151,200 shares in February as released by FINRA. Its up 97.13% from 76,700 shares previously. The stock increased 0.00% or $0.47 during the last trading session, reaching $0.47. About 38,000 shares traded or Infinity% up from the average. AMATA CORP (OTCMKTS:AMCZF) has 0.00% since February 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Since August 15, 2017, it had 0 buys, and 7 selling transactions for $23.58 million activity. Shares for $539,694 were sold by Daniels Jennifer on Wednesday, December 13. Another trade for 126,304 shares valued at $9.32M was sold by Wallace Noel R. Marsili Daniel B had sold 14,000 shares worth $1.00M. Another trade for 10,000 shares valued at $705,797 was made by MOISON FRANCK J on Wednesday, February 7. 36,215 shares valued at $2.58M were sold by JAKOBSEN HENNING I on Monday, February 5. The insider HANCOCK ELLEN M sold 4,676 shares worth $346,581. 3,833 shares valued at $273,868 were sold by Verduin Patricia on Tuesday, August 15.

The stock increased 2.30% or $1.6 during the last trading session, reaching $71.22. About 3.62M shares traded. Colgate-Palmolive Company (NYSE:CL) has risen 6.23% since February 16, 2017 and is uptrending. It has underperformed by 10.47% the S&P500.

Investors sentiment is 0.9 in 2017 Q3. Its the same as in 2017Q2. It is without change, as 52 investors sold Colgate-Palmolive Company shares while 437 reduced holdings. only 92 funds opened positions while 350 raised stakes. 617.24 million shares or 0.04% less from 617.46 million shares in 2017Q2 were reported. London Of Virginia invested in 0.07% or 130,372 shares. Connecticut-based Eagle Ridge Investment Mgmt has invested 0.3% in Colgate-Palmolive Company (NYSE:CL). Glenmede Trust Na stated it has 0.29% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Wolverine Asset Mngmt Llc has 349 shares. Cantab Capital Prns Llp stated it has 13,479 shares. American Tru Advsrs Lc has invested 0.24% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Community Bank Na holds 0.14% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 17,653 shares. Atwood And Palmer, a Missouri-based fund reported 41,400 shares. Pettyjohn Wood & White stated it has 3,086 shares. Murphy Pohlad Asset Mgmt Ltd Liability Company reported 29,545 shares. 600,000 are owned by Manikay Prtnrs Limited Liability. Manchester Cap Mgmt Ltd Liability reported 4,968 shares. Raymond James Finance Services Inc accumulated 236,128 shares or 0.11% of the stock. Fjarde Ap invested in 0.23% or 166,229 shares. Newman Dignan Sheerar owns 3,956 shares or 0.15% of their US portfolio.

Among 25 analysts covering Colgate-Palmolive (NYSE:CL), 6 have Buy rating, 1 Sell and 18 Hold. Therefore 24% are positive. Colgate-Palmolive has $88 highest and $65 lowest target. $73.34’s average target is 2.98% above currents $71.22 stock price. Colgate-Palmolive had 65 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained the shares of CL in report on Thursday, January 4 with “Hold” rating. On Friday, July 29 the stock rating was downgraded by BNP Paribas to “Neutral”. The firm has “Hold” rating by KeyBanc Capital Markets given on Wednesday, November 22. The stock of Colgate-Palmolive Company (NYSE:CL) has “Hold” rating given on Friday, May 26 by RBC Capital Markets. Citigroup downgraded the stock to “Neutral” rating in Monday, January 30 report. UBS maintained it with “Neutral” rating and $78 target in Friday, July 29 report. The stock of Colgate-Palmolive Company (NYSE:CL) has “Neutral” rating given on Tuesday, January 30 by Citigroup. The stock has “Hold” rating by Jefferies on Tuesday, May 30. The stock has “Hold” rating by S&P Research on Monday, November 2. The firm has “Overweight” rating by Morgan Stanley given on Monday, September 25.

Colgate-Palmolive Company, together with its subsidiaries, makes and sells consumer products worldwide. The company has market cap of $62.54 billion. It operates through two divisions, Oral, Personal and Home Care; and Pet Nutrition. It has a 31.24 P/E ratio. The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.